Neuroscience-based app for alcohol reduction and habit change
Reframe builds a mobile-first habit-change platform (Swift/SwiftUI on iOS, React/Node.js backend) grounded in neuroscience research, not behavioral rules. The hiring mix—marketing and support roles dominating over engineering—reflects a consumer health app in growth and customer acquisition mode, supported by clinical partnerships at Emory and Harvard. Active projects center on personalized habit tracking, multi-channel customer engagement, and platform UX, suggesting the company is scaling beyond early-stage product-market fit toward retention and expansion.
Reframe is a consumer health app launched in 2018 and headquartered in Atlanta. The platform guides users toward reducing alcohol consumption or quitting entirely, using habit-formation science rather than abstinence-only frameworks. The company partners with academic researchers and clinical teams to develop its core program. With 51–200 employees, the organization operates as a product + marketing + support business serving individual users and, implicitly, healthcare partners or employers; the small ops and product teams suggest product decisions are closely tied to user feedback and market demand.
iOS (Swift, SwiftUI, UIKit), web frontend (React, Vue, Svelte, Tailwind CSS), backend (Node.js, Python, Elixir, Go, Rust), hosting (AWS, Cloudflare), and containerization (Docker, Kubernetes).
Current projects include improving platform UX, building a personalized habit-alteration ecosystem, executing multi-channel marketing campaigns across customer lifecycle, and developing lead nurturing tactics.
Reframe's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.